John E. Levine

occupation: hematologist, oncologist

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 56

Date

Title

Authors

2018-06-01

Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine

Andrew C. Harris, Jaap J. Boelens, Kwang Woo Ahn, Mingwei Fei, Allistair Abraham, Christopher C Dvorak, Cesar Freytes, Robert Peter Gale, Sanghee Hong, Hillard M Lazarus, Taiga Nishihori, Tracey O'Brien, Kirsten M Williams, Marcelo C Pasquini, John E. Levine, Alison Wakoff Loren, Shin Mineishi
2014-06

Making the genomic leap in HCT: application of second-generation sequencing to clinical advances in hematopoietic cell transplantation

Yun Rose Li, John E. Levine, Hakon Hakonarson
2014-04-15

Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation

John E. Levine
2014-08-01

Less (bacterial diversity) is more (deaths)

John E. Levine
2014-06-02

Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes

John E. Levine, Sophie Paczesny, Erin Gatza, Lawrence Chang, John M Magenau, David Ian Hanauer
2014-06-02

Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantation

John E. Levine, Andrew C. Harris, Sophie Paczesny, Erin Gatza, Lawrence Chang, Attaphol Pawarode, John M Magenau, Gregory A Yanik
2014-02-17

The impact of recent vincristine on human hematopoietic progenitor cell collection in pediatric patients with central nervous system tumors

John E. Levine
2014-01-31

Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease

Matthias Edinger, John E. Levine
2013-11-30

Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial

Sophie Paczesny, John E. Levine, Jan H Beumer, Charles A. Dinarello, Keith Stockerl-Goldstein, Lawrence Chang, Attaphol Pawarode, John M Magenau, Gregory A Yanik, Oleg I Krijanovski
2013-06-12

Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality

John E. Levine, Andrew C. Harris, Joel K Greenson
2013-12-20

Plasma CXCL9 elevations correlate with chronic GVHD diagnosis

John E. Levine, Sophie Paczesny, Mary E D Flowers, Stephanie J. Lee, Lawrence Chang, Paul J Martin
2013-07-25

Impact of psychological screening on routine outpatient care of hematopoietic cell transplantation survivors

John E. Levine
2012-12-19

Children's Oncology Group's 2013 blueprint for research: stem cell transplantation

John E. Levine, Stephan A Grupp
2012-01-27

Plasma biomarkers of lower gastrointestinal and liver acute GVHD

Andrew C. Harris, John E. Levine, Sophie Paczesny, Takanori Teshima, Karin Landfried, Koichi Akashi, Mark T Vander Lugt
2012-10-12

Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes

Andrew C. Harris, John E. Levine, Attaphol Pawarode, John M Magenau, Gregory A Yanik, Shin Mineishi
2012-02-16

Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)

John E. Levine, Suhag Parikh, Kirk R Schultz, Stephen Spellman, Theodore C Moore
2012-12-12

Lymphocyte phenotype during therapy for acute graft-versus-host disease: a brief report from BMT-CTN 0302

John E. Levine
2012-01-01

Hematopoietic stem cell transplantation for severe congenital neutropenia

John E. Levine
2012-01-01

The 2012 education supplement on hematopoietic cell transplantation

John E. Levine
2011-10-06

Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease

Andrew C. Harris, John E. Levine, Sophie Paczesny, Joel K Greenson, Takanori Teshima, Karin Landfried, Koichi Akashi, Mark T Vander Lugt, Alice Chin
2011-12-10

Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantation

John E. Levine, Eric S. White, Andrew C. Harris, Gregory A Yanik, Mark T Vander Lugt, Shin Mineishi
2011-03-08

Implications of TNF-α in the pathogenesis and management of GVHD

John E. Levine
2011-05-01

Successful unrelated donor cord blood transplantation for Glanzmann's thrombasthenia

John E. Levine
2010-01-01

Elafin is a biomarker of graft-versus-host disease of the skin

John E. Levine, VITOR MARCEL FAÇA, Sophie Paczesny, Gregory A Yanik, Alice Chin, Shin Mineishi, David Ian Hanauer
2010-02-01

Pathogenesis and management of graft-versus-host disease

John E. Levine
2010-03-01

Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network

John E. Levine
2009-01-01

Plasma biomarkers in graft-versus-host disease: a new era?

John E. Levine, Sophie Paczesny
2009-03-23

Reduced intensity versus full myeloablative stem cell transplant for advanced CLL

John E. Levine
2009-01-12

Outcomes after auto-SCT in African Americans with multiple myeloma

John E. Levine
2009-01-01

Treatment versus transplant for challenging hematologic disorders

John E. Levine
2009-03-11

Graft-versus-host disease

John E. Levine
2008-04-01

Successful treatment of refractory immune hemolysis following unrelated cord blood transplant with Campath-1H.

John E. Levine

Human - wd:Q56956100

Welcome to Inventaire

the library of your friends and communities

learn more